Apr 1, 2015 • 8:00 am EDT Corbus Pharmaceuticals Announces Presentation of Positive Data on Anti-Fibrotic Effects of Resunab™ in a Preclinical Model of Lung Fibrosis at the Experimental Biology 2015 Scientific Conference
Mar 9, 2015 • 8:35 am EDT Corbus Pharmaceuticals' IND Receives Clearance From FDA to Initiate Phase 2 Trials in Scleroderma With Its Novel Specialized Pro-Resolving Mediator Drug Resunab™
Feb 11, 2015 • 7:35 am EST Corbus Pharmaceuticals to Present at the Leerink Global Healthcare Conference on February 11, 2015
Feb 10, 2015 • 7:05 am EST Corbus Pharmaceuticals Reports 2014 Financial Results and Provides 2015 Business Update
Feb 2, 2015 • 8:05 am EST Corbus Pharmaceuticals to Present at the 17th Annual BIO CEO & Investor Conference on February 9, 2015
Dec 3, 2014 • 8:05 am EST Corbus Pharmaceuticals to Present at the Oppenheimer 25th Annual Healthcare Conference on December 10, 2014
Dec 1, 2014 • 8:30 am EST Corbus Pharmaceuticals to Present at VirtualInvestorConferences.com Online Event on December 4, 2014
Nov 13, 2014 • 6:00 am EST Corbus Pharmaceuticals Reports 2014 Third Quarter Results and Business Update